Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder that affects the motor neurons in the brain and spinal cord. It is characterized by muscle weakness, difficulty speaking, and difficulty swallowing. As the disease progresses, it can lead to paralysis and eventually death. Treatment options are limited and there is no cure. The ALS market is a subset of the larger neurology market. It is a growing market, driven by increasing awareness of the disease and the development of new treatments. There is a need for more effective treatments and therapies to improve the quality of life for those living with ALS. Companies in the ALS market include Biogen, Novartis, Sanofi, and Teva Pharmaceuticals. These companies are developing treatments and therapies to improve the lives of those living with ALS. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
